ORBITA-2 & PCI; BP Control & Increasing Medication Prescriptions; Rapid Initiation & Titration in GRMT for Patients with HFrEF
In this week’s View, Dr. Eagle looks at the results of the ORBITA-2 Trial and its use in stress echocardiography before PCI. He then discusses the proportion of patients achieving blood pressure (BP) control plateaus despite increasing medication prescriptions. Finally, Dr. Eagle explores the use of rapid initiation and titration in guideline-recommended medical therapy (GRMT) in patients with heart failure with reduced ejection fraction (HFrEF).
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Atherosclerotic Disease (CAD/PAD), Acute Heart Failure, Interventions and Coronary Artery Disease, Interventions and Imaging, Echocardiography/Ultrasound, Hypertension, Acute Coronary Syndromes
Keywords: Percutaneous Coronary Intervention, Ischemia, Angina Pectoris, Echocardiography, Coronary Artery Disease, National Cardiovascular Data Registries, PINNACLE Registry, Antihypertensive Agents, Blood Pressure, Outpatients, Hypertension, Sodium-Glucose Transporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists, Heart Failure, Angiotensin-Converting Enzyme Inhibitors, EaglesEyeView
